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Tumor necrosis factor (TNF)-like weak inducer of apoptosis
(TWEAK, TNFSF12) is a member of the TNF superfamily.
TWEAK activates the Fn14 receptor, and may regulate
apoptosis, proliferation, and inflammation, processes that
play a significant role in pathological conditions. However,
there is little information on the function and regulation of
this system in the kidney. Therefore, TWEAK and Fn14
expression were studied in cultured murine tubular epithelial
MCT cells and in mice in vivo. The effect of TWEAK on cell
death was determined. We found that TWEAK and Fn14
expression was increased in experimental acute renal failure
induced by folic acid. Cultured tubular cells express both
TWEAK and the Fn14 receptor. TWEAK did not induce cell
death in non-stimulated tubular cells. However, in cells
costimulated with TNFa/interferon-gamma, TWEAK induced
apoptosis through the activation of the Fn14 receptor.
Apoptosis was associated with activation of caspase-8,
caspase-9, and caspase-3, Bid cleavage, and evidence of
mitochondrial injury. There was no evidence of endoplasmic
reticulum stress. A pan-caspase inhibitor benzyloxycarbonyl-
Val-Ala-DL-Asp prevented TWEAK-induced apoptosis, but it
sensitized cells to necrosis via generation of reactive oxygen
species. In conclusion, cooperation between inflammatory
cytokines results in tubular cell death. TWEAK and Fn14 may
play a role in renal tubular cell injury.
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Tubular cells compose most of the mass of the functioning
kidney. Loss of renal tubular cells characterizes both acute
and chronic renal failure.1 Acute tubular necrosis is the most
common form of acute renal failure.2 In humans, tubular cell
death was the best histopathological correlate of renal
dysfunction in acute tubular necrosis.3,4 The term acute
tubular necrosis was originated in necropsy studies before the
phenomenon of apoptosis had been acknowledged as a
separate form of cell death. However, in human acute tubular
necrosis apoptosis was the most common form of tubular cell
death, albeit necrosis was also present.3,4 Thus, the term acute
tubular injury is now more widely employed and will be used
throughout the text Apoptosis is an active mode of cell death
under molecular control.1 Extracellular and intracellular
molecules that provide multiple regulatory and contra-
regulatory pathways tightly regulate apoptosis. These mole-
cules are potential targets for therapeutic intervention.
However, the design of appropriate therapeutic strategies
requires a correct understanding of the molecular regulation
of renal cell apoptosis. In this regard, the role of apoptosis
regulatory molecules may vary in a cell type- and stimulus-
specific manner.5 Members of the tumor necrosis factor
(TNF) superfamily of cytokines regulate several cell re-
sponses, including proliferation, differentiation, and death.6,7
Two of these cytokines, TNFa and FasL, have been extensively
studied in renal injury and shown to be involved in renal
damage.8–14 TNF-like weak inducer of apoptosis (TWEAK,
TNFSF12) is a recently described member of the TNF
superfamily of structurally related cytokines.15,16 TWEAK
functions as a both type II transmembrane protein and as a
cleaved soluble molecule. TWEAK may promote cell death,
but it also modulates cell proliferation, inflammation, and
angiogenesis.15,17–20 Fibroblast growth factor-inducible 14
(Fn14) is a cell membrane TWEAK receptor.20–22 Both
TWEAK and its receptor, Fn14, are present in the healthy
adult kidney.15,21 However, there is little information on the
regulation of the expression and the role of TWEAK and its
receptor in kidney disease.
We now report that TWEAK induces tubular cell
apoptosis in the presence of proinflammatory cytokines
and that these findings may be relevant to the pathogenesis of
acute renal failure.
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RESULTS
Increased expression of TWEAK and Fn14 in experimental
acute renal failure
In an experimental model of acute tubular injury character-
ized by tubular cell apoptosis,10 expression of both TWEAK
(Figure 1a and b) and its receptor (Figure 1c and d) increased
both at the messenger RNA (mRNA) and protein level. Fn14
was localized to injured tubules (Figure 1e). Based on this
observation we studied the contribution of TWEAK to
cultured tubular cell death.
Fn14 is expressed and inducible in renal tubular cells
Renal tubular murine cortical tubular cell line (MCT) cells
constitutively express TWEAK and Fn14 (Figure 2a–c).
Constitutive Fn14 expression is low, but it was upregulated
by proinflammatory cytokines (TNFa, interferon-gamma
(INFg)) alone or in combination (Figure 2c). Increased
Fn14 expression was also observed when the ligand, TWEAK,
was combined with TNFa/INFg. This combination increased
Fn14 in a time-dependent manner at the mRNA (Figure 2b)
and protein (Figure 2c) levels. Quantitative polymerase chain
reaction (PCR) confirmed a fourfold increase of Fn14 mRNA
at 3 h, with return to baseline by 24 h (data not shown).
TWEAK induces apoptosis in tubular cells exposed to
proinflammatory cytokines
We next evaluated a potential lethal activity of TWEAK in
tubular cells. TWEAK did not induce apoptosis in non-
stimulated tubular cells (Figure 3a). By contrast, costimula-
tion with TNFa and INFg resulted in sensitization to
TWEAK-induced apoptosis (Figure 3b). Neither INFg nor
TNFa sensitized, by themselves, to death induced by TWEAK
(Figure 3c). Features of apoptosis included the presence of
hypodiploid cells and morphology (nuclear shrinkage,
condensation, and fragmentation as well as decreased cell
size) (Figure 4a and b).
Apoptosis increased with concentration of TWEAK
(Figure 3b). For further experiments we chose a concentra-
tion of 100 ng/ml of TWEAK, which induces around 30% of
the cells to undergo apoptosis in 24 h (Figure 3b). Under
these conditions, TWEAK-induced apoptosis was time-
dependent and was apparent following 18 h of incubation
(Figure 5). TNFa/INFg induced delayed apoptosis in tubular
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Figure 1 | Increased expression of TWEAK and Fn14 in experi-
mental acute renal failure (ARF). In ARF induced by a single
injection of folic acid the expression of (a) TWEAK mRNA (real-time
PCR) and (b) protein (Western blot), (c) Fn14 mRNA (real-time PCR),
and (d) protein (Western blot) were increased. (e) Fn14 was localized
to injured, dilated tubules (arrows) (immunohistochemistry). Both
proximal and distal tubules expressed Fn14, which colocalized with
TWEAK mainly in proximal tubules (inset, e). Note the presence of
apoptotic cells in the tubular lumen (arrowhead). Mean (s.d.) of five
mice. *Po0.05 vs control, **Po0.01 vs control (original magnification
 400).
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Figure 2 | TWEAK and Fn14 expression in proximal tubular MCT
cells. (a) Western blot analysis of TWEAK protein expression.
(b) Northern blot analysis of Fn14 mRNA expression in TWEAK/TNFa/
INFg-treated cells. (c) Western blot analysis of Fn14 protein expression
in cells treated with cytokines.
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cells (Figure 5). This delayed apoptosis maybe explained by
the lethal effect of TNF in MCT cells.23 That is, TWEAK-
induced apoptosis in a proinflammatory milieu is accelerated
when compared to that induced by TNFa alone.
MCT cells constitutively express FasL and Fas, and Fas
expression is increased by TNFa/INFg.12 To rule out an
autocrine role for FasL in cell death, cells were cultured with a
decoy receptor which antagonizes TWEAK or with FasL
blocking antibodies, in the presence of TWEAK/TNFa/INFg.
The decoy receptor protected against apoptosis, whereas
blocking FasL was only marginally protective (Figure 6a).
However, the decoy receptor did not significantly protect
against apoptosis induced by the TNFa/INFg combination
at 48 h (TNFa/INFg 4077.8%, TNFa/INFg/Fn14:Fc 33.57
8.4%, P¼NS).
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Figure 3 | Modulation of TWEAK-induced apoptosis in MCT cells.
Cell death was assessed by flow cytometry of DNA content after
culture for 24 h in the presence of recombinant TWEAK and different
proinflammatory cytokines. (a) TWEAK alone did not induce
apoptosis. (b) In the presence of TNFa (30 ng/ml) and INFg (30 U/ml),
TWEAK induced apoptosis in a dose-dependent manner. (c) Neither
INFg nor TNFa sensitized, by themselves, to TWEAK-induced cell
death. Mean (s.d.) of four independent experiments. *Po0.01 vs
control.
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Figure 4 | TWEAK-induced tubular cell death in a proinflammatory environment has features of apoptosis. (a) Flow cytometry of DNA
content. Note hypodiploid, apoptotic cells (A0) among those treated with TWEAK/TNFa/INFg for 24 h. (b) Characteristic shrunk, pyknotic,
fragmented nuclei are present among 40,60-diamidino-2-phenylindole-stained, TWEAK/TNFa/INFg-treated cells, but not among control or
TNFa/INFg-treated cells (original magnification  200).
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Figure 5 | TWEAK-induced apoptosis in the presence of TNFa/INFc
is time-dependent. Cell death was assessed by flow cytometry of
DNA content after culture in the presence of 100 ng/ml TWEAK and
TNFa/INFg. A significant increase in apoptosis was noted at 18 h. In
the absence of TWEAK, a significant increase in cell death was
delayed for 48 h. Mean (s.d.) of four independent experiments.
*Po0.01 vs control.
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Fn14 mediates TWEAK-induced apoptosis in renal tubular
cells
The combination of TWEAK/TNFa/INFg increased the
expression of Fn14 receptor (Figure 2b and c). ITEM-4, an
anti-Fn14 neutralizing antibody, prevented TWEAK/TNFa/
INFg-induced apoptosis (Figure 6b). These results suggest
that in a proinflammatory environment TWEAK induces
apoptosis in the tubular epithelium through Fn14 activation.
TWEAK-induced apoptosis is caspase-dependent
We next investigated caspase involvement in apoptosis
induced by TWEAK in the presence of TNFa/INFg. The
combination of cytokines activated caspase-3, -8, and -9
(Figure 7a–c). TWEAK/TNFa/INFg rapidly induced the
appearance of truncated Bid, which preceded caspase-9 and
-3 activation (Figure 7c). Bid is a caspase-8 target in death
receptor-initiated apoptosis. Caspase-9 processing started at
1 h (Figure 7c). Processing of caspase-3 started at 3 h, as
shown by the appearance of caspase-3 cleavage product in
Western blots (Figure 7c). Caspase-3 is mainly activated by
caspase-8 or caspase-9.24
Truncated Bid translocates to the mitochondria and elicits
cytochrome c release to the cytosol, where the latter activates
caspase-9.25 Cytochrome c was released from the mitochon-
dria of cells treated with TWEAK/TNFa/INFg (Figure 7d
and e).
TWEAK does not induce endoplasmic reticulum stress
Growth-arrest and DNA damage (GADD)153 is induced
during cell death triggered by endoplasmic reticulum stress.26
GADD153 expression did not change in tubular cells treated
with TWEAK/TNFa/INFg, unlike in cells treated with the
endoplasmic reticulum stress or tunicamycin (Figure 7f).
Moreover, cleavage of endoplasmic reticulum-specific cas-
pase-12 was not detected in cells treated with TWEAK/TNFa/
INFg (Figure 7f).
Effect of zVAD on TWEAK-induced cell death and apoptosis
We next studied the effect of caspase inhibition on apoptosis
(Figure 8). Benzyloxycarbonyl-Val-Ala-DL-Asp(zVAD)-fluor-
omethylketone is a broad-spectrum inhibitor of caspases.27
zVAD-fluoromethylketone inhibited caspase-8 and caspase-3
activity (Figure 7a), caspase-3 processing (Figure 7b), and
apoptosis, efficiently blocking DNA hypoploidy, but it did
not prevent cell death (Figure 8d). Notably, cells stimulated
with TWEAK in the presence of zVAD and cytokines
exhibited a necrotic morphology, which was characterized
by trypan blue staining (79% of the cells). Similar results
were found in cells treated with TWEAK/TNFa/INFg and
caspase-8 inhibitor (data not shown). A role for TWEAK in
necrotic death in MCT cells in the presence of caspase
inhibition was confirmed, because a TWEAK antagonist
prevented the cell death (Figure 8e). In addition, zVAD
did not promote cell death in the presence of TNFa/INFg
(Figure 8h).
These results indicate that in a proinflammatory
environment TWEAK primarily induces apoptosis in MCT
cells, but it can also induce necrosis when caspases are
inactivated.
Involvement of reactive oxygen intermediates in
TWEAK-induced necrosis
Recently, it has been reported that mitochondrial stress-
induced reactive oxygen species were responsible for TNFa or
anti-Fas monoclonal antibody-induced necrosis, which was
abrogated by antioxidants such as butylated hydroxyanisole
(BHA).28,29 Thus, we tested whether BHA could inhibit
TWEAK/TNFa/INFg-induced necrosis in zVAD-treated cells.
The necrotic morphology was completely abrogated by BHA
(Figure 8f). These results suggest that caspase inhibition
could sensitize MCT cells to TWEAK-induced necrosis via
reactive oxygen species-dependent pathway.
DISCUSSION
TWEAK and Fn14 expression has been detected in the
normal kidney.15,21 We now show that both proteins are
upregulated in acute tubular injury, suggesting that they may
play a role in kidney disease. In the presence of pro-
inflammatory cytokines, activation of Fn14 leads to tubular
epithelial cell injury. Cell death is associated with caspase-8
activation and recruitment of the mitochondrial pathway of
apoptosis. Caspase inhibitors prevent apoptosis but promote
oxidative stress and a necrotic form of cell death.
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In different cell types TWEAK may promote cell
proliferation or cell death.15–17,19,20,22,30–34 TWEAK has been
shown to promote apoptosis, by itself, in neurons, mono-
cytes, mesangial cells, and certain tumor cell lines.30–33 By
contrast, TWEAK does not induce apoptosis in non-
stimulated tubular cells. Nevertheless, the lethal activity of
TWEAK may require the coincubation with other agents.
TWEAK promotes apoptosis when combined with INFg in
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some tumor cell lines, whereas others remain resistant even in
the presence of this cytokine.15,22 In tubular epithelial cells,
the coincubation with TNFa and INFg sensitizes to apoptosis
induced by TWEAK. This effect was not observed with either
cytokine alone. This requirement for both INFg and TNF is
novel. TNFa/INFg increased Fn14 expression in tubular cells.
The early peak of Fn14 expression (2 h) is consistent with
previous reports, as Fn14 is an immediate-early response
gene.21 Upregulation of Fn14 expression may underlie the
sensitization to apoptosis. In fact, Fn14 transfectants become
sensitive to TWEAK-induced death.22 Alternatively, it has
been suggested that certain functions of TWEAK are
mediated by a second, not yet characterized receptor.35
However, a Fn14 blocker prevented the cytotoxicity of the
cytokine combination on tubular epithelium. This indicates
that Fn14 mediates the lethal effect of TWEAK in tubular
cells. An autocrine activation of the FasL/Fas system was also
considered as a potential cause of cell death. Our group had
previously described that proinflammatory cytokines increase
Fas expression in tubular cells.10 The Fas receptor could
theoretically be activated by autocrine FasL, as tubular
epithelium constitutively expresses FasL.10 FasL blocking
antibody minimally decreased the rate of cell death induced
by TWEAK/TNFa/INFg, suggesting that the mechanism is
indeed active, albeit of little significance in this system.
Next we investigated the intracellular pathways for
apoptosis induced by TWEAK in the presence of TNFa/
INFg. We observed activation of caspase-8, proteolysis of Bid,
release of cytochrome c to the cytosol and activation of
caspase-9 and caspase-3. Proteolysis of Bid pre-dated caspase
9, which in turn, pre-dated caspase-3 activation. This
suggests that, as it is the case for some cell types in response
to activation of death receptors, caspase-8-activated Bid
mediated an amplification loop through the mitochondria.25
Activation of caspases-3, -8, and -9 had previously been
observed in some, but not all, tumor cell lines undergoing
apoptosis induced by TWEAK.22,32 However, it is still unclear
what adaptors mediate this effect, as Fn14 lacks a death
domain.22 On the other hand, we found no evidence
supporting the participation of endoplasmic reticulum stress
in the process. The apoptotic endoplasmic reticulum
response is preserved in MCT cells exposed to paracetamol
or tunicamycin.36 TNF-a alone may induce a delayed
apoptosis in MCT cells, but the time course differs from
that of TWEAK, as there is a lag period of 48 h, which was
confirmed in cells treated with TNFa/INFg.23 In addition, the
intracellular molecular mechanisms differ, as cleavage of Bid
was not observed in the absence of TWEAK. Most
extracellular inputs are not processed in isolation, rather,
multiple inputs are perceived by cells in a proinflammatory
milieu.37 It is difficult to assign the final output to a single
stimulus.37 It is conceivable that similar apoptotic pathways
engaged by both TNFa and TWEAK in the presence of INFg
cooperate in cell death induction.
Possible therapeutic interventions on tubular cell injury
induced by TWEAK were explored. Both TWEAK and Fn14
neutralization were protective. The pancaspase inhibitor
zVAD prevented the activation of caspases, and also
prevented apoptosis. However, zVAD did not prevent
eventual cell death by necrosis. The critical role of TWEAK
in necrosis in cells without active caspases was suggested by
the fact that zVAD did not promote necrosis in cells exposed
only to TNFa/INFg. In addition, a TWEAK antagonist
prevented the necrotic morphology. The induction of
necrosis in cells exposed to members of the TNF superfamily
when caspases are inhibited had been observed pre-
viously.28,29 The effect of pan caspase inhibition on eventual
cell death induced by TWEAK is cell type-specific.22,32
Caspase inhibition prevented both apoptosis and cell
death in a TWEAK-sensitive tumor cell line, whereas this
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Figure 8 | Effect of zVAD on apoptosis and cell death. (a–h) MCT
cells were exposed for 24 h to different stimuli. Contrast phase
microscopic photographs (original magnification  200). An example
representative of at least three independent experiments is shown.
Apoptotic cell death at the indicated conditions is also shown. Cells
were first photographed and then collected for flow cytometry of
DNA content. (d) zVAD prevented apoptosis but did not protect from
cell death. (d) Note cell detachment despite low apoptosis rate in
TWEAK/TNFa/INFg/zVAD treated cells. (e, f) Both Fn14:Fc and BHA
prevented cell death induced by TWEAK/TNFa/INFg/zVAD. (h) zVAD
did not promote cell death in the presence of TNFa/INFg.
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intervention did not prevent necrosis in a cell line that
required INFg for sensitization to the lethal effect of TWEAK,
and it did increase TWEAK-induced cell death in Fn14
transfectants.32 This latter observation is in accordance with
our results suggesting a critical role for Fn14 in the process.
The protection afforded by the antioxidant BHA in tubular
cells treated with TWEAK/TNFa/INFg and zVAD suggests the
involvement of oxidative stress in the necrotic process that
takes place upon caspase inhibition in cytokine-stimulated
cells.38 We can only speculate as to the possible contribution
of this caspase-independent pathway for cell death during
tubular injury in vivo. Even in the absence of therapeutic
intervention, there are endogenous caspase inhibitors that
may theoretically influence the mode of cell death. However,
we do not yet know inhibition of what specific caspase is
important for necrotic cell death to proceed. As tubular cell
injury, including apoptosis and necrosis, is a feature of the
most common form of parenchymal acute renal failure,4
analyzing the pathways by which as single stimulus may
induce either form of cell death will provide new clues to the
process that may be used therapeutically.
TNFa is recognized as a key participant in renal injury.9,13
INFg is also expressed in the kidney during acute tubular
injury.39 Much less is known about TWEAK/Fn14 expression
in renal injury. We now present data showing increased
TWEAK expression in an experimental model of acute
tubular injury characterized by tubular cell apoptosis and
increased TNFa levels.10 This was associated with a 13-fold
increase in Fn14 mRNA and a 2.5-fold increase in tubular cell
Fn14 receptor, suggesting a role for TWEAK/Fn14 in the
process. Potential sources of TWEAK in the kidney include
tubular cells, as shown in the present report, as well as
infiltrating leukocytes.31,40
In summary, TWEAK induces death of renal tubular
epithelial cells under certain microenvironmental conditions,
such a proinflammatory milieu composed of TNFa and INFg.
The conditions of increased TWEAK, TNFa, INFg, and Fn14
expression are observed in experimental acute renal failure.
Caspases and mitochondria are involved in the apoptosis of
tubular cells induced by TWEAK, but there is no evidence of
endoplasmic reticulum stress. The present data identify
TWEAK as a cytokine relevant for renal tubular injury.
Further studies are needed to fully characterize its role in
diverse renal diseases.
MATERIALS AND METHODS
Cells and reagents
MCT cells are a cultured line of proximal tubular epithelial cells that
have been extensively characterized.41 MCT cells were cultured in
Rosewell Park Memorial Institute media 1640 (GIBCO, Grand
Island, NY, USA), 10% decomplemented fetal calf serum, 2 mM
glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin, in 5%
CO2 at 371C.
41
zVAD-fluoromethylketone was from Bachem (Bubendorf, Switzer-
land), Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoremethylketone
(DEVD-fmk) and Z-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylk-
etone (IETD-fmk) from Calbiochem (San Diego, CA, USA). They
were dissolved in dimethylsulfoxide. Final concentration of
dimethylsulfoxide in culture did not modulate cell death.42
Staurosporine (100 nM) and tunicamycin (1 mg/ml) were from
Sigma (St Louis, MO, USA).36,43
TWEAK and Fn14-Fc (Alexis, La¨ufelfingen, Switzerland) were
dissolved in water. Unless otherwise specified the concentration of
TWEAK was 100 ng/ml, Fn14:Fc 5 mg/ml, murine TNFa (Immu-
genex, Los Angeles, CA, USA) 30 ng/ml and human INF-g
(Immugenex) 30 U/ml. MFL3 neutralizing anti-FasL antibody
10 mg/ml (Pharmingen, San Diego, CA, USA), ITEM-4 neutralizing
anti-Fn14 antibody 2.5 mg/ml (Bioscience, San Diego, CA, USA) and
BHA 50 mM (Sigma)12,35,44,45 were also used.
Cell death and apoptosis
Cells (10 000) were seeded in 24-well plates (Costar, Cambridge,
MA, USA) in 10% fetal calf serum Rosewell Park Memorial Institute
media overnight. Thereafter, they were rested in serum-free medium
for 24 h and stimuli were added to subconfluent cells.
Apoptosis was characterized by morphologic and functional
criteria. Nuclei of formalin-fixed cells were stained with propidium
iodide in the presence of RNAse A to observe the typical
morphological changes, as described previously.12 In addition,
nuclei of formalin-fixed cells were stained with 40,60-diamidino-2-
phenylindole (Vector Laboratories Inc, Burlingame, CA, USA). Both
40,60-diamidino-2-phenylindole and propidium iodide staining
yielded similar results. For assessment of apoptosis by flow
cytometry adherent cells were pooled with spontaneously detached
cells, and incubated in 100 mg/ml propidium iodide, 0.05% Nonidet
P-40, 10 mg/ml RNAse A in phosphate-buffered saline at 41C for
41 h. This assay permeabilizes the cells and, thus, it is not based on
the known ability of propidium iodide to enter dead cells. The
percentage of apoptotic cells with decreased DNA staining (A0) was
counted as described previously.12
Western blot
Methods have been described.12 Primary antibodies were rabbit
polyclonal anti-Fn14 1:500,21 anti-TWEAK (1:500, Santa Cruz
Biotechnology, CA, USA), anti-caspase-9 (1:1000, Cell Signalling,
Hertfordshire, UK) anti-caspase-12 (1:1000, Cell Signalling), anti-
cleaved caspase-3 (1:1000, Cell Signalling), anti-GADD153 (1:500,
Santa Cruz), or anti-Bid (1:3000, a gift of SJ Korsmeyer, Dana-Farber
Cancer Institute, Boston, MA, USA). Blots were then probed with
mouse monoclonal anti-tubulin antibody (1:2000, Sigma) and levels
of expression were corrected for minor differences in loading.12
Caspase activity
Caspase-3 activity (MBL, Nagoya, Japan) and caspase-8 activity
(Sigma) were measured following the manufacturer’s instruc-
tions.36,43 In brief, cell extracts (70 mg protein) were incubated with
200 mM DEVD-pNA or Ac-IETD-pNA and pNA light emission was
quantified. Comparison of the absorbance of pNA from an
apoptotic sample with an uninduced control allows determination
of the fold increase in caspase activity.
Cytochrome c release from mitochondria
Release of cytochrome c from mitochondria to cytosol was measured
by Western blot.36,43 Mitochondria-free cytosolic extracts or
mitochondria were electrophoresed on 15% polyacrylamide gels
and analyzed by Western blot. Rabbit polyclonal anti-cytochrome c
(1:500, Santa Cruz Biotechnology) was used. Cytochrome oxidase
subunit IV (1:500, Molecular Probes, Leiden, The Netherlands) is
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not released from mitochondria during apoptosis, and was
used as control. Immunostaining was performed as described
previously.43
Real-time PCR
Total RNA was extracted by the Trizol method (Life technologies,
Carlsbad, CA, USA) and 1 mg was reverse transcribed with the High
Capacity complementary DNA Archive Kit (Applied Biosystems,
Foster City, CA, USA). Real-time PCR reactions were performed on
a ABI Prism 7500 sequence detection PCR system (Applied
Biosystems) according to manufacturer’s protocol and quantitated
with the Prism 7000 System SDS Software (Applied Biosystems).
Expression levels are given as ratios to glyceraldehyde-3-phosphate
dehydrogenase. Pre-developed primer and probe assays were
obtained for murine glyceraldehyde-3-phosphate dehydrogenase,
Fn14, and TWEAK from Applied Biosystems.
Northern hybridization
Forty micrograms total RNA were processed as described
previously.10 The mouse Fn14 complementary DNA hybridization
probe has been described.21 Membranes were then hybridized
to a probe for 28S to adjust for small loading and transfer
variations.
Animal models
Balb/c mice (five- to 7-week-old, IFFA-CREDO, Barcelona, Spain)
were studied in accord with the NIH Guide for the Care and Use of
Laboratory Animals. Folic acid nephropathy is a widely used
classical model of acute renal failure characterized by tubular injury,
including tubular cell apoptosis, as well as tubular cell proliferation,
bone marrow cell dependent regeneration, inflammatory cell
infiltration, and mild fibrosis in a chronic phase.10,44–47 All these
features are present in human acute renal failure and represent a
good model to study the molecular mechanisms regulating these
processes and their therapeutic regulation.46,47 As it is the case for
other forms of acute renal failure, a role of a TNF family member,
TNF; has been demonstrated in the disease.10,23,48 Renal injury was
induced by a single intraperitoneal injection of folic acid (Sigma)
250 mg/kg in 0.3 mol/l sodium bicarbonate (n¼ 5) or vehicle
(n¼ 5)10 and mice were killed 24 h later. Folic acid increased
serum creatinine (1.570.2 vs 0.370.01 mg/dl, Po0.05) and was
associated with evidence of tubular cell apoptosis, such as the
apoptotic morphology (Figure 1e) and internucleosomal DNA
degradation.10
The kidneys were cold saline perfused in situ before removal. One
kidney was fixed in buffered formalin, embedded in paraffin and
stained with hematoxylin–eosin, and Masson’s trichrome or used for
immunohistochemistry. The other was snap-frozen in liquid
nitrogen for RNA and protein studies.
Immunohistochemistry
Immunohistochemistry was carried out as described previously10 in
paraffin-embedded tissue sections 5 mm thick. Anti-Fn14 antibody
was used at a concentration of 10 mg/ml. Anti-TWEAK antibody was
used at a concentration of 4 mg/ml (Santa Cruz Biotechnology). For
colocalization experiments, specular kidney sections were stained
with anti-TWEAK and anti-Fn14 antibody. Sections were counter-
stained with Carazzi’s hematoxylin. Negative controls included
incubation with a nonspecific immunoglobulin of the same isotype
as the primary antibody.
Statistics
Results are expressed as mean7s.d. Significance at the Po0.05 level
was assessed by non-parametric Mann–Whitney test for two groups
of data and Kruskal–Wallis for three of more groups by means of the
SigmaStat statistical software (Jandel, San Rafael, CA, USA).
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